EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Computational pathology applied to clinical colorectal cancer cohorts identifies immune and endothelial cell spatial patterns predictive of outcome

Nicholas Trahearn iD, Chirine Sakr, Abhirup Banerjee, Seung Hyun Lee, Ann-Marie Baker iD, Hemant M Kocher iD, Valentina Angerilli, Federica Morano, Francesca Bergamo, Giulia Maddalena, Rossana Intini, Chiara Cremolini and 6 more

The Journal of Pathology · 2025-02 · 265 (2) · 198-210

DOI: 10.1002/path.6378 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2025-01-09. Written by Nicholas Trahearn and 17 co-authors. Institution: Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. Major MEDLINE topics: Colorectal Neoplasms, Tumor Microenvironment. Cited 14 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCI NIH HHS, Cancer Research UK, Wellcome Trust.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Colorectal cancer (CRC) is a histologically heterogeneous disease with variable clinical outcome. The role the tumour microenvironment (TME) plays in determining tumour progression is complex and not fully understood. To improve our understanding, it is critical that the TME is studied systematically within clinically annotated patient cohorts with long‐term follow‐up. Here we studied the TME in three clinical cohorts of metastatic CRC with diverse molecular subtype and treatment history. The MISSONI cohort included cases with microsatellite instability that received immunotherapy ( n = 59, 24 months median follow‐up). The BRAF cohort included BRAF V600E mutant microsatellite stable (MSS) cancers ( n = 141, 24 months median follow‐up). The VALENTINO cohort included RAS/RAF WT MSS cases who received chemotherapy and anti‐EGFR therapy ( n = 175, 32 months median follow‐up). Using a Deep learning cell classifier, trained upon >38,000 pathologist annotations, to detect eight cell types within H&E‐stained sections of CRC, we quantified the spatial tissue organisation and colocalisation of cell types across these cohorts. We found that the ratio of infiltrating endothelial cells to cancer cells, a possible marker of vascular invasion, was an independent predictor of progression‐free survival (PFS) in the BRAF+MISSONI cohort ( p = 0.033, HR = 1.44, CI = 1.029–2.01). In the VALENTINO cohort, this pattern was also an independent PFS predictor in TP53 mutant patients ( p = 0.009, HR = 0.59, CI = 0.40–0.88). Tumour‐infiltrating lymphocytes were an independent predictor of PFS in BRAF+MISSONI ( p = 0.016, HR = 0.36, CI = 0.153–0.83). Elevated tumour‐infiltrating macrophages were predictive of improved PFS in the MISSONI cohort ( p = 0.031). We validated our cell classification using highly multiplexed immunofluorescence for 17 markers applied to the same sections that were analysed by the classifier ( n = 26 cases). These findings uncovered important microenvironmental factors that underpin treatment response across and within CRC molecular subtypes, while providing an atlas of the distribution of 180 million cells in 375 clinically annotated CRC patients. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Colorectal NeoplasmsTumor MicroenvironmentHumansMicrosatellite InstabilityEndothelial CellsBiomarkers, TumorFemaleMaleAgedProto-Oncogene Proteins B-rafMiddle AgedLymphocytes, Tumor-InfiltratingComputational BiologyMutationTreatment Outcome

Author keywords

computational pathology; artificial intelligence; colorectal cancer; endothelia…

Substances

Biomarkers, TumorProto-Oncogene Proteins B-rafBRAF protein, human

Authors and institutions

  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • UCL Cancer Institute, UCL, London, UK.
  • Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Systems Oncology group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
  • Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

ORCID profiles: Nicholas Trahearn, Ann-Marie Baker, Hemant M Kocher, Matteo Fassan, Andrea Sottoriva

Funding

  • NCI NIH HHS
  • Cancer Research UK
  • Wellcome Trust
  • Ministero della Salute
  • NIH HHS
  • Associazione Italiana per la Ricerca sul Cancro
  • Medical Research Council
  • National Institutes of Health

Cite

APA

Trahearn, N., Sakr, C., Banerjee, A., Lee, S. H., Baker, A. M., Kocher, H. M., Angerilli, V., Morano, F., Bergamo, F., Maddalena, G., Intini, R., Cremolini, C., Caravagna, G., Graham, T., Pietrantonio, F., Lonardi, S., Fassan, M., & Sottoriva, A. (2025). Computational pathology applied to clinical colorectal cancer cohorts identifies immune and endothelial cell spatial patterns predictive of outcome. The Journal of Pathology, 265(2), 198-210. https://doi.org/10.1002/path.6378

Vancouver

Trahearn N, Sakr C, Banerjee A, Lee SH, Baker AM, Kocher HM, et al. Computational pathology applied to clinical colorectal cancer cohorts identifies immune and endothelial cell spatial patterns predictive of outcome. The Journal of Pathology. 2025;265(2):198-210. doi:10.1002/path.6378

BibTeX
@article{Trahearn2025,
  author = {Trahearn, Nicholas and Sakr, Chirine and Banerjee, Abhirup and Lee, Seung Hyun and Baker, Ann-Marie and Kocher, Hemant M and Angerilli, Valentina and Morano, Federica and Bergamo, Francesca and Maddalena, Giulia and Intini, Rossana and Cremolini, Chiara and Caravagna, Giulio and Graham, Trevor and Pietrantonio, Filippo and Lonardi, Sara and Fassan, Matteo and Sottoriva, Andrea},
  title = {Computational pathology applied to clinical colorectal cancer cohorts identifies immune and endothelial cell spatial patterns predictive of outcome},
  journal = {The Journal of Pathology},
  year = {2025},
  volume = {265},
  number = {2},
  pages = {198--210},
  doi = {10.1002/path.6378}
}
Start for free →